8-K
FORM8K
- Company
- Viridian Therapeutics, Inc.\DE
- Filed
- March 13, 2019
- Period of Report
- March 13, 2019
- Accession Number
- 0001628280-19-002862
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →